Artificial Intelligence in Patient Counselling

Artificial Intelligence in Patient Counselling explores the transformative role of artificial intelligence in enhancing patient counseling and education. The book delves into how cutting-edge AI technology is reshaping the healthcare landscape, improving patient experiences, and driving better health outcomes. It provides a comprehensive overview of the ways AI can address the challenges of personalized and effective patient care. Sections cover a wide range of topics, including the creation of personalized treatment plans through AI's analysis of patient data, the emergence of AI-powered virtual health assistants for 24/7 support, and the use of predictive analytics to identify early disease progression.

Additionally, it explores AI-enhanced medical imaging, empathetic AI chatbots, ethical considerations, and real-world case studies that illustrate the tangible benefits of AI in patient counseling and education. By offering insights from leading experts, it empowers readers to navigate the evolving healthcare landscape with confidence and compassion. The book provides essential knowledge and tools for improving patient outcomes and modernizing patient care through AI-driven solutions, making it a valuable resource for understanding the impact of AI on patient care and education.

• Delves into how AI analyzes patient data, including medical histories, genetics, and lifestyles to create tailored treatment plans
• Highlights the role of AI-driven virtual health assistants and chatbots that provide 24/7 support, empathetic conversations, and proactive counseling
• Discusses the ethical implications of using AI in healthcare
• Presents real-world case studies that illustrate the practical benefits and challenges of AI in patient counseling and education

Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination.

Dr. Meghraj Vivekanand Suryawanshi is a distinguished academician and researcher with over seven years of experience in pharmaceutical education and research. He holds a B.Pharm degree from SIPS, Lonavala, Pune (2016), an M.Pharm from renowned RCPIPER, Shirpur (2018), an MBA from renowned JNU, Jaipur (2022), and a Ph.D. from renowned JNU, Jaipur (2024). Additionally, he earned a Postgraduate Diploma in Clinical Research (PDCR) from CCS, New Delhi (2016). Dr. Suryawanshi's academic and research journey is marked by significant achievements, including 55 publications in WOS/SCOPUS/UGC CARE-listed journals, conference proceedings, and technical notes. He is Co-Founder of AllWell Nutritech LLP, Jalgaon, Maharashtra. He has authored 08 books, contributed to 22 book chapters, and guided several postgraduate research projects. His expertise spans polymer science and chemistry, novel drug delivery systems, product development, and intellectual property rights. With one granted international patent, seven published national patents, and one copyright, he has demonstrated remarkable innovation in formulations for rheumatoid arthritis, levothyroxine sodium implants, and thermosensitive vaginal gels. Dr. Suryawanshi has secured research/seminar grants exceeding 1.2 lakh from Government of Gujarat (GSBTM/DST and SSIP) and managed projects worth 50 lakh at Cerelia Nutritech Pvt. Ltd. and IIT Delhi. Recognized with awards such as the Young Scientist Award, Best Researcher Award and Best Innovation Award by DST-PDEU Gandhinagar, he continues to contribute to pharmaceutical sciences through entrepreneurial ventures, mentoring, and impactful research with H-index 7 and i10-index 7. He is certified Scientific and Medical Writer, and Systematic Literature Reviewer by EIEN Mumbai; DigiRivera Surat.

Dr. Jigna Prajapati has rich experience of years in academia, research and IT industry, holding Doctorate in Computer Science. She published more than fifty international & national publication. She has secured many best paper awards in international & national Conferences in research category. Besides teaching she is Motivator, Online and Offline Trainer & counsellor. Leading a team which involves work of Infrastructure/ Academic Planning & Development, Network Design & Management, Examination, Key Administration & Research. She is actively working in field of Artificial Intelligence & Machine Learning focusing on healthcare. Her expert domains are as artificial intelligence, machine learning, software engineering & emerging technologies. She works on research projects that explore new techniques and methods in their area of Machine learning and collaborates with other researchers both within their institution and around the world. She has played an important role in educating the next generation of computer scientists.

Currently working as an Assistant Professor in the Department of Pharmacology and Toxicology at College of Pharmacy King Saud University, Riyadh Saudi Arabia. Before joining King Saud University worked as a Post-Doctoral Scholar in the School of Medicine, University of Kentucky, Lexington, USA.. Currently involved in teaching, research, and research is mainly focused on finding the molecular mechanisms involved in cancer chemoprevention and chemotherapy-induced vital organ toxicity and their prevention using natural and synthetic compounds using in-vivo and in-vitro models. He has published more than 130 research, review and book chapters in highly reputed international journals.